Searching News Database: ACAPODENE
HSMN NewsFeed - 12 Jul 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
HSMN NewsFeed - 10 Apr 2007
GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory Affairs
GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory Affairs
HSMN NewsFeed - 4 Apr 2007
GTx, Inc. Appoints Ronald A. Morton, Jr. MD, FACS as Chief Medical Officer
GTx, Inc. Appoints Ronald A. Morton, Jr. MD, FACS as Chief Medical Officer
HSMN NewsFeed - 2 Feb 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
HSMN NewsFeed - 7 Sep 2006
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
GTx and Ipsen Enter Into Partnership Agreement for the European Rights of Acapodene(R)
HSMN NewsFeed - 7 Sep 2006
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
Ipsen and GTx Enter into Partnership Agreement for The European Rights of Acapodene(R)
Additional items found! 17
Members Archive contains
17 additional stories matching:
ACAPODENE
(Password required)
ACAPODENE
(Password required)